Kaleyathodi Naras Bhat, MD
NPI 1316904725ActiveIndividual· Allergy & Immunology· Concord, CA
Allergy & Immunology (MD) with Jiva Health Inc and 1 other group, practicing in Concord, California. 1,312 Medicare patients in 2024, $745,250 paid; nearly all of their 203 Part D prescriptions were generic (90%). Glaxosmithkline, LLC. was the largest of 5 companies reporting payments in 2025, $303.53 in all, mostly food and beverage.
Overview
| NPI | 1316904725 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | Apr 28, 2006 |
| Last updated in NPPES | Dec 20, 2016 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Allergy & Immunology Primary | 207K00000X | A25677 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Allergy/Immunology (CA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 1,312 |
|---|---|
| Services billed | 4,295 across 19 procedure codes |
| Paid by Medicare | $745,250 |
Part D prescriptions in 2024
| Prescriptions (claims) | 203 · 402 30-day fills |
|---|---|
| Patients | 42 |
| Total drug cost | $11,495 |
| Generic share | 90% of claims |
Education and affiliations
| Graduation year | 1969 |
|---|---|
| Medicare specialty | Allergy/Immunology |
| Secondary specialties | Internal Medicine |
| Telehealth | Offers telehealth |
Medical groups
- Jiva Health IncConcord, CA · 51 clinicians
- Jiva Health Primary CareConcord, CA · 8 clinicians
Industry payments (Open Payments)
- 2025$303.53 · 10 payments from 5 companies
- 2024$331.22 · 8 payments from 4 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Glaxosmithkline, LLC. | $155.84 | 3 |
| Astrazeneca Pharmaceuticals LP | $80.13 | 4 |
| Avadel Cns Pharmaceuticals, LLC | $29.71 | 1 |
| Novartis Pharmaceuticals Corporation | $24.01 | 1 |
| Amgen Inc. | $13.84 | 1 |
What the 2025 payments were for
- Food and Beverage$303.53 · 10 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records